Testing Advances in Epilepsy Treatment
Researchers at Case Western Reserve University have successfully prevented epileptic seizures in animal models by pre-emptively directing a low-frequency stimulus to the nerve fibers in the brain.
That technique differs substantially from current human therapies recently approved by the U.S. Food and Drug Administration, in which doctors now employ a much higher frequency directly into brain tissue and sometimes only after a seizure has started.
Those methods, while an alternative to previous treatments in which brain tissue is surgically removed, still only reduce seizures by about 50% and in just about half of the patients treated, said researcher Dominique Durand, the Elmer Lincoln Lindseth Professor of Biomedical Engineering at Case Western Reserve and director of its Neural Engineering Center.
But Durand and PhD student Nick Couturier have demonstrated a success rate of more than 90% in animal testing—and by a method that works before a seizure even occurs.
13th Annual International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery
Feb. 21-23, 2020; Lake Buena Vista, Fla.
2020 Winter Clinics for Cranial & Spinal Surgery
Feb. 23-27, 2020; Snowmass Village, Colo.
71st Annual Meeting of the Southern Neurosurgical Society
Feb. 26-29, 2020; Richmond, Va.
3rd Annual Mayo Clinic Advances and Innovations in Complex Neuroscience Patient Care: Brain and Spine 2020
Feb. 27-29, 2020; Sedona, Ariz.
Multidisciplinary Neuro-Oncology Symposium: Updates in Medical and Surgical Management of Brain Tumors
March 6-7, 2020; Orlando, Fla.